141 related articles for article (PubMed ID: 23765875)
1. Stimulation of somatic cell reprogramming by ERas-Akt-FoxO1 signaling axis.
Yu Y; Liang D; Tian Q; Chen X; Jiang B; Chou BK; Hu P; Cheng L; Gao P; Li J; Wang G
Stem Cells; 2014 Feb; 32(2):349-63. PubMed ID: 23765875
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Akt Signaling Modulated Reprogramming of Somatic Cells.
Chen YH; Su CC; Deng W; Lock LF; Donovan PJ; Kayala MA; Baldi P; Lee HC; Chen Y; Wang PH
Sci Rep; 2019 Jul; 9(1):9919. PubMed ID: 31289326
[TBL] [Abstract][Full Text] [Related]
3. The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells.
Nakhaei-Rad S; Nakhaeizadeh H; Götze S; Kordes C; Sawitza I; Hoffmann MJ; Franke M; Schulz WA; Scheller J; Piekorz RP; Häussinger D; Ahmadian MR
J Biol Chem; 2016 Apr; 291(16):8399-413. PubMed ID: 26884329
[TBL] [Abstract][Full Text] [Related]
4. The roles of ERAS during cell lineage specification of mouse early embryonic development.
Zhao ZA; Yu Y; Ma HX; Wang XX; Lu X; Zhai Y; Zhang X; Wang H; Li L
Open Biol; 2015 Aug; 5(8):. PubMed ID: 26269429
[TBL] [Abstract][Full Text] [Related]
5. CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency.
Wang XQ; Lo CM; Chen L; Ngan ES; Xu A; Poon RY
Cell Death Differ; 2017 Jan; 24(1):38-48. PubMed ID: 27636107
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
Evans-Anderson HJ; Alfieri CM; Yutzey KE
Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of Akt isoforms on somatic cell reprogramming.
Tang Y; Jiang Z; Luo Y; Zhao X; Wang L; Norris C; Tian XC
J Cell Sci; 2014 Sep; 127(Pt 18):3998-4008. PubMed ID: 25037569
[TBL] [Abstract][Full Text] [Related]
8. LRP16 gene protects mouse insulinoma MIN6 cells against fatty acid-induced apoptosis through Akt/FoxO1 signaling.
Li XJ; Guo QH; Wang X; Xue B; Sun LQ; Meng QT; Lu JM; Mu YM
Chin Med J (Engl); 2012 May; 125(10):1695-702. PubMed ID: 22800886
[TBL] [Abstract][Full Text] [Related]
9. AKT signaling is associated with epigenetic reprogramming via the upregulation of TET and its cofactor, alpha-ketoglutarate during iPSC generation.
Sekita Y; Sugiura Y; Matsumoto A; Kawasaki Y; Akasaka K; Konno R; Shimizu M; Ito T; Sugiyama E; Yamazaki T; Kanai E; Nakamura T; Suematsu M; Ishino F; Kodera Y; Kohda T; Kimura T
Stem Cell Res Ther; 2021 Sep; 12(1):510. PubMed ID: 34563253
[TBL] [Abstract][Full Text] [Related]
10. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells.
Zhang X; Yalcin S; Lee DF; Yeh TY; Lee SM; Su J; Mungamuri SK; Rimmelé P; Kennedy M; Sellers R; Landthaler M; Tuschl T; Chi NW; Lemischka I; Keller G; Ghaffari S
Nat Cell Biol; 2011 Jul; 13(9):1092-9. PubMed ID: 21804543
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of FOXO1/3 promotes vascular calcification.
Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
[TBL] [Abstract][Full Text] [Related]
12. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
[TBL] [Abstract][Full Text] [Related]
13. Effects of Akt signaling on nuclear reprogramming.
Nakamura T; Inoue K; Ogawa S; Umehara H; Ogonuki N; Miki H; Kimura T; Ogura A; Nakano T
Genes Cells; 2008 Dec; 13(12):1269-77. PubMed ID: 19032345
[TBL] [Abstract][Full Text] [Related]
14. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.
Fang L; Wang H; Zhou L; Yu D
Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted regulation of somatic cell reprogramming by mRNA translational control.
Tahmasebi S; Alain T; Rajasekhar VK; Zhang JP; Prager-Khoutorsky M; Khoutorsky A; Dogan Y; Gkogkas CG; Petroulakis E; Sylvestre A; Ghorbani M; Assadian S; Yamanaka Y; Vinagolu-Baur JR; Teodoro JG; Kim K; Yang XJ; Sonenberg N
Cell Stem Cell; 2014 May; 14(5):606-16. PubMed ID: 24630793
[TBL] [Abstract][Full Text] [Related]
16. Foxd1 is a mediator and indicator of the cell reprogramming process.
Koga M; Matsuda M; Kawamura T; Sogo T; Shigeno A; Nishida E; Ebisuya M
Nat Commun; 2014; 5():3197. PubMed ID: 24496101
[TBL] [Abstract][Full Text] [Related]
17. The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells.
Fang D; Huang Z; Guan H; Liu J; Yao B; Xiao H; Li Y
Mol Med Rep; 2012 Jan; 5(1):233-8. PubMed ID: 21964769
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin.
Abdelnour-Berchtold E; Cerantola Y; Roulin D; Dormond-Meuwly A; Demartines N; Dormond O
Anticancer Res; 2010 Mar; 30(3):799-804. PubMed ID: 20392999
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
